GLP-1 Drugs Linked to Dramatically Lower Death Rates in Colon Cancer Patients
10 days ago
- #GLP-1
- #obesity
- #colon cancer
- GLP-1 receptor agonists like Ozempic and Wegovy linked to significantly lower death rates in colon cancer patients.
- Study of 6,800 patients showed GLP-1 users had less than half the mortality rate within five years compared to non-users.
- Survival benefit was most notable in patients with a BMI over 35, suggesting anti-inflammatory and metabolic improvements.
- Potential mechanisms include reduced inflammation, improved insulin sensitivity, weight loss, and direct anti-cancer effects.
- Authors call for clinical trials to confirm findings and explore GLP-1 drugs' role in improving cancer survival rates.